2,3',4,5'-tetramethoxystilbene,
2,4,3',5'-tetramethoxystilbene,
3,5,2',4'-tetramethoxy-trans-stilbene,
TMS cpd,
24144-92-1,
tms,
(E)-1-(3,5-Dimethoxystyryl)-2,4-dimethoxybenzene,
2,3',4,5'-tetramethoxystilbene,
2,4,3',5'-tetramethoxystilbene,
CHEMBL46909,
20578-92-1,
Cytochrome P450 1B1 Inhibitor, TMS,
(E)-2,3′,4,5′-Tetramethoxystilbene,
SR-01000597603,
3,5,2',4'-tetramethoxy-trans-stilbene,
AC1NS4S6,
Oxyresveratrol tetramethyl ether,
SCHEMBL4366766,
CHEBI:92804,
1-[2,(3,5-Dimethoxyphenyl)ethenyl]-2,4-dimethoxybenzene,
JDBCWSHYEQUBLW-AATRIKPKSA-N,
HMS3648A21,
HMS3676F17,
BCP21292,
EX-A1015,
ZINC3875137,
1747AB,
BDBM50108052,
BN0522,
MFCD03428621,
AKOS015967529,
CS-5626,
VZ20197,
(E)-2,3',4,5'-tetramethoxystilbene,
Trans-2,3',4,5'-tetramethoxystilbene,
trans-2,4,3',5'-tetramethoxystilbene,
AJ-46412,
BC221612,
HY-19340,
trans-2,4,3'',5''-tetramethoxystilbene,
AX8154295,
B6768,
1-(3,5-Dimethoxystyryl)-2,4-dimethoxybenzene,
S-7732,
144T921,
2,4,3',5'-tetramethoxystilbene, >=98% (HPLC),
J-015362,
SR-01000597603-1,
SR-01000597603-2,
BRD-K45988865-001-01-0,
(E)-4,5'-(ethene-1,2-diyl)bis(1,3-dimethoxybenzene),
(E)?-?1-?(3,?5-?Dimethoxystyryl)?-?2,?4-?dimethoxybenzene,
1-[(E)-2-(2,4-dimethoxyphenyl)ethenyl]-3,5-dimethoxybenzene,
1-[(E)-2-(3,5-dimethoxyphenyl)vinyl]-2,4-dimethoxybenzene,
Benzene, 1-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]-2,4-dimethoxy-,
Benzene,1-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]-2,4-dimethoxy-,
TMS cpd,
C18H20O4,
CID5354004,
NCGC00025194-01,
A11977,
C440850,
1,3-DIMETHOXY-5-[ -2- -VINYL]-BENZENE,